Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-30 @ 12:20 AM
Study NCT ID:
NCT05487495
Status:
WITHDRAWN
Last Update Posted:
2024-11-14
First Post:
2022-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma
Sponsor:
Beijing Boren Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-01
First Submit QC Date:
None
Study First Post Date:
2022-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-12
Last Update Post Date:
2024-11-14
Last Update Post Date Type:
ACTUAL